Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
QuintilesIMS
Cipla
Argus Health
Baxter
Chubb
Dow
Boehringer Ingelheim

Generated: August 21, 2018

DrugPatentWatch Database Preview

Vifor Fresenius Company Profile

« Back to Dashboard

What is the competitive landscape for VIFOR FRESENIUS, and what generic alternatives to VIFOR FRESENIUS drugs are available?

VIFOR FRESENIUS has one approved drug.

There are two US patents protecting VIFOR FRESENIUS drugs.

There are sixty-five patent family members on VIFOR FRESENIUS drugs in thirty-eight countries and seven supplementary protection certificates in seven countries.

Summary for Vifor Fresenius
International Patents:65
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Vifor Fresenius

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes 9,561,251 ➤ Try a Free Trial Y ➤ Try a Free Trial
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes 6,174,442 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Vifor Fresenius Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0868125/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: FERRIOXYHYDROXIDUM/SACCHARUM/AMYLA; REGISTRATION NO/DATE: SWISSMEDIC 62986 22.01.2015
5 Finland ➤ Try a Free Trial
00710 Netherlands ➤ Try a Free Trial PRODUCT NAME: MENGSEL VAN POLYNUCLEAIRE IJZER (III)-OXYHYDROXIDE, SUCROSE EN ZETMEEL; REGISTRATION NO/DATE: EU/1/14/943 20140826
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
AstraZeneca
Healthtrust
Argus Health
Baxter
Farmers Insurance
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.